Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02544399
Other study ID # 0801092
Secondary ID 2008-A01265-50
Status Completed
Phase N/A
First received September 7, 2015
Last updated September 8, 2015
Start date November 2009
Est. completion date June 2013

Study information

Verified date September 2015
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Observational

Clinical Trial Summary

After the age of 50, one in three women and one in eight men will experience at least one fragility fracture during the rest of their lives. It is currently recognized that physical activity has an osteogenic actions, especially when it includes the impact transmitted to the skeleton. In this context, the investigators propose a study to determine whether the regular practice of golf could be particularly beneficial for the skeleton, not only in the lower limbs, due to repeated impacts to the ground when it requires sustained walking, but also the upper limbs due to the impacts transmitted by the club at the time of striking the ball, as has been amply demonstrated with racquet sports.


Description:

Each patient will have 1 blood samples and 1 measure of bone by 3D micro-tomography (3D CT Scan).These examinations and sampling will take place on 1 day.


Recruitment information / eligibility

Status Completed
Enrollment 67
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 60 Years to 75 Years
Eligibility Inclusion Criteria:

- Golfers: Regular playing golf for over 2 years at 8 to 12 hours per week recruited into golf clubs.

- Walkers: regular practice of walking for over 2 years at 8 to 12 hours per week recruited into the walking clubs.

- Sedentary: no intensive physical activity (<2 hours / week), recruited in clubs seniors.

Exclusion Criteria:

- concomitant bone disease ,

- Hip prosthesis the dominant side

- Endocrinopathy

- hypercalcemia, vitamin D deficiency, hypo- or hyper calciuria

- Active smoking (more than 5 cigarettes / day), chronic alcoholism,

- Treatments received in the previous six months and resounding on bone metabolism such growth promoters, all osteoporosis, corticosteroids.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
3D CT scan
Measure of bone micro-architecture by 3D micro-tomography

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne

Outcome

Type Measure Description Time frame Safety issue
Primary Bone volume / tissue volume Measure of Bone volume / tissue volume by the 3D CT scan day 1 Yes
See also
  Status Clinical Trial Phase
Completed NCT03464266 - The Kampala Women's Bone Study Phase 4